TB500 Benefits: The Research, Graded | telos rx
TB500 benefits research: BPC-157 + TB-500 stack for connective tissue
← Back to blog
tb 500 benefits

TB500 Benefits: What the Research Actually Shows, Graded

By TelosRX Editorial Team Updated

TB500 benefits are mostly an extrapolation. The claims people repeat, faster soft-tissue recovery, flexibility, wound repair, hair and heart support, come largely from animal and cell studies of thymosin beta 4 (Tβ4), the natural protein TB-500 is based on. No controlled human trial of injected TB-500 has been published.

That does not make the research meaningless. It makes it early. This guide takes each claimed benefit in turn, shows the best study we could verify for it, and grades how far that evidence really goes. Where there is a gap, we say so.

Also searched as: tb 500 benefits, tb500 peptide benefits, tb-500 peptide benefits, what does tb500 do.

First, what does TB500 do?

TB-500 is a short synthetic peptide built around the active actin-binding segment of Tβ4, the sequence LKKTETQ, rather than the whole 43-amino-acid protein (Ho 2012). Tβ4 itself holds on to loose actin units inside cells, which is tied to how cells move and reorganise after injury. A major review describes it as released by platelets and immune cells after injury and studied for cell migration, new blood vessel growth and reduced scarring (Goldstein 2012).

So "what does TB500 do" has two answers. In theory, it is designed to mimic that active region. In practice, almost all the data are on full Tβ4, so every TB500 benefit below carries that asterisk. If you are new to the molecule, start with our pillar guide, what is TB500.

telos rx does not offer TB-500 on its own. It is prescribed only as part of the compounded BPC-157 + TB-500 stack, after an online review by a US-licensed provider.

See if the BPC-157 + TB-500 stack is right for you

TB500 benefits graded by evidence level

Here is the scorecard. "Evidence level" describes what kind of study exists, not whether the benefit is likely in you.

Claimed benefit Best evidence we could verify Evidence level Main gap
Soft-tissue (tendon) recovery TB-500 in a rat Achilles tendon repair model, 8 rats per group (Biçer 2026) Animal only, one small study No human trial; no muscle or ligament data in people
Flexibility and joint mobility No published study found No direct research Claim rests on anecdote
Wound repair Full Tβ4 in rat wounds (Malinda 1999); phase 2 topical Tβ4 in venous ulcers (Guarnera 2010) Animal plus small early human trials of topical Tβ4 Topical full protein, not injected TB-500
Hair growth Full Tβ4 in rats and mice (Philp 2004) Animal only No human hair trial
Heart tissue Full Tβ4 after induced heart injury in mice (Bock-Marquette 2004) Animal only No human cardiac outcome data
Eye surface Tβ4 eye drops for dry eye, 72 people (Sosne 2015) Small human phase 2, topical Tβ4 Primary endpoints not met; not TB-500

Read across the table and one thing stands out: none of the TB500 benefits has human data for injected TB-500. The only human trials used topical, full-length Tβ4 on skin or eyes.

TB500 benefits for recovery: what the research shows

Soft-tissue recovery: the most searched TB500 benefit

This is why most people look up TB-500 peptide benefits. The most direct study is recent: a 2026 rat study repaired a cut Achilles tendon and gave TB-500, BPC-157, both, or nothing for four weeks. The TB-500 group had better tissue scores and a higher load before failure than controls. The combination did not beat either peptide alone (Biçer 2026).

The authors called it exploratory and asked for dose and longer-term studies. Eight rats per group, injected into the abdomen, at a weight-based dose, is a long way from a person with a sore hamstring. Our planned guide to TB-500 for injury recovery goes deeper into the injury research, and the older tissue repair research overview covers more preclinical papers.

Flexibility: the weakest of the TB500 benefits

Flexibility and "looser joints" appear on almost every list of TB500 benefits. We could not find a single published study that measured flexibility or range of motion with TB-500 or Tβ4. The claim appears to come from personal reports and from stretching the animal tissue findings into a new outcome.

That matters because flexibility is easy to change with stretching, rest, warm-up and time. Without a controlled comparison, there is no way to credit a peptide for it.

Wound repair: the strongest TB500 benefit signal, with a twist

Wound repair has the deepest body of work. In rats, Tβ4 applied to the skin or given by injection into the abdomen increased new skin cover over wounds and was linked to more collagen and new blood vessels (Malinda 1999). Small phase 2 trials then tested topical Tβ4 in people with venous leg ulcers and pressure ulcers. In the venous ulcer study of 73 patients, safety was comparable to placebo and the authors described a possible effect at one dose (Guarnera 2010; summary in Treadwell 2012).

The twist: these were gels of the full protein on open wounds, not injected TB-500. They are the closest thing to human evidence in this whole field, and they still do not transfer directly to the product people search for.

Want a provider to weigh the research against your health history? The intake is online and asynchronous, and every prescription is subject to medical approval by a licensed provider.

Start your provider review

Hair growth

Rodent work found that Tβ4 stimulated hair growth and drew hair follicle stem cells to move and mature (Philp 2004). It is an interesting mechanism. It has not been tested in a human hair-loss trial. Our article on TB-500 for hair loss covers the questions a provider will ask.

Heart tissue

In a well-known mouse study, Tβ4 supported heart muscle cell migration and survival after a blocked coronary artery, and treated mice had better heart function (Bock-Marquette 2004). It helped spark interest in Tβ4 as a cardiac research target. There are no human cardiac outcome data, and nobody should use TB-500 for heart health.

What the TB500 benefits evidence does not tell you

  • Dose in humans. Animal doses are weight-based and route-specific. They do not translate to a human protocol. A provider sets any dose; see our planned guide on how providers dose TB-500.
  • Timeline. There is no evidence-based timeline for any TB500 benefit in people. Our planned article on how long TB-500 takes to work explains why.
  • Long-term safety. Reported or theorised effects include injection-site reactions, headache, nausea, dizziness, fatigue and flushing. Because Tβ4 is studied for blood vessel growth, people with cancer or a cancer history are commonly advised to avoid it, and it is not for pregnancy or breastfeeding.
  • Combination effects. Pairing with BPC-157 is popular, but the one rat study that tested it found no added benefit. More in our planned guide to Wolverine stack benefits.

Legal status, sport and safe access

TB-500 is not FDA-approved for any use. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6, with 1 abstention, to recommend adding it to the list of bulk substances usable in compounding. The vote is non-binding: voted to recommend, pending FDA rulemaking. On October 28, 2026, HHS announced an interim enforcement discretion policy under which it does not intend to take enforcement action against state-licensed pharmacies that compound single-ingredient TB-500 for subcutaneous or intramuscular injection with a valid prescription, if strict sourcing, testing and reporting conditions are met. It covers TB-500 only as a single-ingredient product, not blended with BPC-157 in one vial. The telos rx stack is supplied as two separate vials, so neither vial is a blend. The policy is temporary while FDA decides through rulemaking, it is not FDA approval, and HHS can revisit it. See TB-500 regulatory status after the PCAC vote.

TB-500 is on the WADA Prohibited List at all times (S0, and S2 as a growth factor). If you are a tested athlete, none of these TB500 benefits are relevant to you.

Grey-market "research use only" vials are not made for human use, and their dose, purity and even identity are unverified. The prescription route at telos rx works differently: an online intake, an asynchronous review by a US-licensed provider, and, if approved, the compounded BPC-157 + TB-500 stack from a licensed US pharmacy as two separate single-ingredient vials under one provider-set plan, at $133 per month. telos rx does not offer TB-500 on its own, approval is not guaranteed, and plans can be paused or cancelled. Compare the two peptides in BPC-157 vs TB-500, or see the full details on the stack page.

Frequently asked questions

What are the main TB500 benefits people claim?

The most common claims are faster soft-tissue recovery, better flexibility, wound repair, hair growth and heart protection. Each comes mainly from animal or cell studies of the parent protein thymosin beta 4. None has been shown in controlled human trials of injected TB-500.

What does TB500 do in the body?

Research suggests the parent protein, thymosin beta 4, binds and holds loose actin units inside cells, which is linked to how cells move toward injured tissue. It has also been studied for new blood vessel growth and reduced scarring in animals. Whether TB-500 does the same in people is unknown.

Are TB 500 benefits shown in humans?

No. There are no published controlled trials of injected TB-500 in people. The human trials that exist used topical full-length thymosin beta 4 for skin ulcers or dry eye, with mixed results. TB500 benefits for muscles, tendons and joints have not been shown in humans.

Does TB-500 help with flexibility?

We found no published study that measured flexibility or range of motion with TB-500 or thymosin beta 4. The flexibility claim seems to come from anecdote and from extrapolating animal tissue findings. It is the weakest of the popular claims.

Are TB500 peptide benefits for hair real?

Rodent studies found thymosin beta 4 stimulated hair growth and hair follicle stem cell activity. No published human trial has tested TB-500 for hair loss. It is an interesting early signal, not an established use.

What do TB500 benefits mean for athletes?

Nothing usable, because TB-500 is on the WADA Prohibited List at all times. Tested athletes should not use it, and anti-doping laboratories have published methods to detect it.

Can I get TB-500 alone to try these benefits?

No. telos rx does not offer TB-500 on its own. It is only prescribed as part of the compounded BPC-157 + TB-500 stack, after an online review by a US-licensed provider, and approval is not guaranteed. No benefit is promised.

Ready for a licensed provider's view? Start the online intake for the BPC-157 + TB-500 stack. telos rx does not offer TB-500 on its own, and approval is not guaranteed.

See if the BPC-157 + TB-500 stack is right for you

This article is for general education and is not medical advice. TB-500 is not FDA-approved, BPC-157 is not FDA-approved, and compounded medications are not FDA-approved. No benefit or result is promised. All prescriptions are subject to medical approval by a licensed provider; approval is not guaranteed. TB-500 is prohibited by WADA at all times. Individual experiences vary. telos rx is an online-first, asynchronous telehealth service, and medications are compounded by a licensed US pharmacy.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX